Cas 864359-23-9,4-(2-Ethyl-4-methoxy-phenyl)-piperazine-1-carboxylic acid tert-butyl ester

864359-23-9

Post Buying Request

Basic information

Product Name: 4-(2-Ethyl-4-methoxy-phenyl)-piperazine-1-carboxylic acid tert-butyl ester
Synonyms: 4-(2-Ethyl-4-methoxy-phenyl)-piperazine-1-carboxylic acid tert-butyl ester
CAS NO:864359-23-9
Molecular Formula:
Molecular Weight: 320.432
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 4-(2-Ethyl-4-methoxy-phenyl)-piperazine-1-carboxylic acid tert-butyl ester(CAS DataBase Reference)
NIST Chemistry Reference: 4-(2-Ethyl-4-methoxy-phenyl)-piperazine-1-carboxylic acid tert-butyl ester(864359-23-9)
EPA Substance Registry System: 4-(2-Ethyl-4-methoxy-phenyl)-piperazine-1-carboxylic acid tert-butyl ester(864359-23-9)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 864359-23-9(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

864359-23-9 Suppliers

Recommended suppliers

864359-23-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 864359-23-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,6,4,3,5 and 9 respectively; the second part has 2 digits, 2 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 864359-23:
(8*8)+(7*6)+(6*4)+(5*3)+(4*5)+(3*9)+(2*2)+(1*3)=199
199 % 10 = 9
So 864359-23-9 is a valid CAS Registry Number.

864359-23-9Upstream product

864359-23-9Downstream Products

864359-23-9Relevant academic research and scientific papers

Immunosuppressant Compounds and Compositions

-

Page/Page column 14, (2008/06/13)

The present invention relates to immunosuppressant, process for their production, their uses and pharmaceutical compositions containing them. The invention provides a novel class of compounds useful in the treatment or prevention of diseases or disorders mediated by lymphocyte interactions, particularly diseases associated with EDG receptor mediated signal transduction.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 864359-23-9